Nisa Investment Advisors’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $69.1K | Sell |
5,764
-600
| -9% | -$4.98K | ﹤0.01% | 1723 |
|
|
2026
Q1 | $53.3K | Buy |
6,364
+4,139
| +186% | +$43.5K | ﹤0.01% | 1641 |
|
|
2025
Q4 | $32K | Buy |
2,225
+661
| +42% | +$8.24K | ﹤0.01% | 1766 |
|
|
2025
Q3 | $15.1K | Sell |
1,564
-37
| -2% | -$327 | ﹤0.01% | 2112 |
|
|
2025
Q2 | $13.1K | Buy |
+1,601
| New | +$13.4K | ﹤0.01% | 2134 |
|
|
2025
Q1 | – | Sell |
-39
| Closed | -$301 | – | 3050 |
|
|
2024
Q4 | $301 | Sell |
39
-58
| -60% | -$545 | ﹤0.01% | 2897 |
|
|
2024
Q3 | $1.02K | Buy |
97
+3
| +3% | +$37 | ﹤0.01% | 2571 |
|
|
2024
Q2 | $1.1K | Buy |
94
+10
| +12% | +$156 | ﹤0.01% | 2498 |
|
|
2024
Q1 | $1.77K | Buy |
84
+48
| +133% | +$854 | ﹤0.01% | 2256 |
|
|
2023
Q4 | $646 | Sell |
36
-1,419
| -98% | -$25K | ﹤0.01% | 2357 |
|
|
2023
Q3 | $23.9K | Sell |
1,455
-140
| -9% | -$2.54K | ﹤0.01% | 1958 |
|
|
2023
Q2 | $31.9K | Buy |
1,595
+1,388
| +671% | +$26.7K | ﹤0.01% | 1913 |
|
|
2023
Q1 | $4K | Sell |
207
-1,650
| -89% | -$36.5K | ﹤0.01% | 2264 |
|
|
2022
Q4 | $42K | Hold |
1,857
| – | – | ﹤0.01% | 1835 |
|
|
2022
Q3 | $44K | Buy |
1,857
+32
| +2% | +$949 | ﹤0.01% | 1787 |
|
|
2022
Q2 | $45K | Sell |
1,825
-300
| -14% | -$7.5K | ﹤0.01% | 1765 |
|
|
2022
Q1 | $71K | Sell |
2,125
-930
| -30% | -$25.8K | ﹤0.01% | 1738 |
|
|
2021
Q4 | $81K | Buy |
3,055
+150
| +5% | +$5.11K | ﹤0.01% | 1593 |
|
|
2021
Q3 | $122K | Hold |
2,905
| – | – | ﹤0.01% | 1607 |
|
|
2021
Q2 | $113K | Buy |
2,905
+530
| +22% | +$19K | ﹤0.01% | 1632 |
|
|
2021
Q1 | $81K | Sell |
2,375
-2,200
| -48% | -$93.8K | ﹤0.01% | 1840 |
|
|
2020
Q4 | $208K | Buy |
4,575
+1,860
| +69% | +$65K | ﹤0.01% | 1452 |
|
|
2020
Q3 | $75K | Buy |
2,715
+1,400
| +106% | +$45.6K | ﹤0.01% | 1641 |
|
|
2020
Q2 | $48K | Buy |
1,315
+470
| +56% | +$17.5K | ﹤0.01% | 1597 |
|
|
2020
Q1 | $27K | Buy |
845
+460
| +119% | +$19.2K | ﹤0.01% | 1655 |
|
|
2019
Q4 | $16K | Hold |
385
| – | – | ﹤0.01% | 1734 |
|
|
2019
Q3 | $14K | Buy |
385
+60
| +18% | +$2.43K | ﹤0.01% | 1704 |
|
|
2019
Q2 | $17K | Hold |
325
| – | – | ﹤0.01% | 1630 |
|
|
2019
Q1 | $19K | Buy |
325
+150
| +86% | +$7.43K | ﹤0.01% | 1622 |
|
|
2018
Q4 | $7K | Hold |
175
| – | – | ﹤0.01% | 1730 |
|
|
2018
Q3 | $13K | Sell |
175
-325
| -65% | -$23.4K | ﹤0.01% | 1650 |
|
|
2018
Q2 | $36K | Hold |
500
| – | – | ﹤0.01% | 1488 |
|
|
2018
Q1 | $14K | Hold |
500
| – | – | ﹤0.01% | 1553 |
|
|
2017
Q4 | $17K | Hold |
500
| – | – | ﹤0.01% | 1587 |
|
|
2017
Q3 | $16K | Hold |
500
| – | – | ﹤0.01% | 1598 |
|
|
2017
Q2 | $10K | Buy |
+500
| New | +$9.68K | ﹤0.01% | 1718 |
|
Other funds holding RGNX
RG
Nisa Investment Advisors's RGNX Position: Q2 2026 in Review
Nisa Investment Advisors reduced its Regenxbio (RGNX) stake by 9.4% in Q2 2026, selling an estimated $4.98K and leaving 5,764 shares worth $69.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1723.
Nisa Investment Advisors first reported a position in RGNX in Q2 2017 and has held it in 36 quarters since. The position peaked at $208K in Q4 2020. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- Nisa Investment Advisors held 5,764 shares of Regenxbio worth $69.1K as of Q2 2026.
- Nisa Investment Advisors sold 600 Regenxbio shares in Q2 2026, an estimated $4.98K.
- Regenxbio made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1723 holding.
- Nisa Investment Advisors first reported a position in Regenxbio in Q2 2017 and has held it in 36 quarters since.
- Nisa Investment Advisors's Regenxbio position peaked at $208K in Q4 2020.
- 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.